KU Hematology & Medical Oncology Review 2019
R

KU ASCO GU 2019 Updates: Enzalutamide vs. Apalutamide in Metastatic Hormone-Sensitive Prostate Cancer and Enfortumab in Metastatic Bladder Cancer

By KU Hematology & Medical Oncology Review 2019 FEATURING Rahul Parikh
By KU Hematology & Medical Oncology Review 2019 FEATURING Rahul Parikh
847 views
August 22, 2019
Comments 0
Login to view comments. Click here to Login

Featured Video

18:17
Exelixis

Treatment Decisions When Initiating a Tyrosine Kinase Inhibitor and …

Feat. K. Hanna, J. Strauss

Featured Video

17:48
Exelixis

Hypothetical Patient Case: 1L Advanced Renal Cell Carcinoma With Mul…

Feat. R. Alter, A. Rezazadeh

Recommended

RENALC-BLADDR-PROSCA 2024

BLADDR 2024 - Hybrid Global Forum on GU Oncology

Wed, Nov 27, 2024
See 1 other
14:16

ASCO® GU 2024 Summary: "Important Prostate Cancer Take-Home Messages"

Insights from 2024 ASCO® GU Annual Meeting

E. Efstathiou

2.6K views

·

9 months ago
16:05

Recent GU Developments and Their Clinical Implications

Insights from 2024 ASCO® GU Annual Meeting

T. Powles, B. Rini

1.5K views

·

8 months ago
17:50

Clinical Highlights From AACR 2024: Trials Evaluating Selected New T…

AdventHealth

G. Sonpavde

1.8K views

·

6 months ago
27:04

Cancer Screening Molecular Tools

Fengting Yan

2.5K views

·

11 months ago
11:56

Aggressive Variant Prostate Cancer: Definition, Diagnosis, Treatment…

Ana Aparicio

1.6K views

·

11 months ago
29:25

Hyperprogression in Cancer Treated With Immunotherapy

Northwestern Medicine Oncology and Hematology

Y. Chae

1.2K views

·

6 months ago
21:43

Surgical Management of High-Risk and Locally Advanced Prostate Cancer

Yale Cancer Center

I. Kim

416 views

·

1 month ago
09:14

AUA Advanced Prostate Cancer Guidelines: 2023 Update

Robert Dreicer

1.3K views

·

10 months ago
21:54

ASCO® 2024 Prostate Cancer Take-Home Messages

2024 ASCO® Annual Meeting Insights Hub

E. Efstathiou

584 views

·

3 months ago
03:05

Testosterone Suppression and Recovery in Patients With Advanced Pros…

Benjamin L. Maughan

647 views

·

5 months ago
34:26

ASCO® 2024 Summary: "Prostate Cancer Highlights"

2024 ASCO® Annual Meeting Insights Hub

N. Reizine, K. Tawagi

558 views

·

4 months ago
15:58

Best of Bladder Cancer and RCC From ESMO 2023 and GU ASCO 2024

Total Health

M. Reimers

529 views

·

8 months ago
08:54

ESMO 2024 Summary: GU Practice-Changing Trial Results of PEACE-3 (mC…

2024 ESMO Annual Meeting Insights Hub

R. Dreicer

248 views

·

1 month ago
12:10

GnRH Agonists vs. Antagonists in Prostate Cancer

Patrick Campbell

312 views

·

2 months ago
18:43

Precision Therapies for Prostate Cancer

University of Miami Sylvester Comprehensive Cancer Center

M. Bilusic

325 views

·

2 months ago
06:27

ASCO® 2024 Insights: "Evaluation of Persistence and Adherence for Or…

2024 ASCO® Annual Meeting Insights Hub

J. Hafron

634 views

·

5 months ago
05:18

ASCO® 2023 Insights: "PSMAddition - A Phase 3 Trial to Compare Treat…

Insights from 2023 ASCO® Annual Meeting

S. Tagawa

1.8K views

·

1 year ago
05:27

Understanding PSMA PET Scans in Prostate Cancer Diagnosis

GRACE

K. Jatwani, K. Tawagi, M. Kurian

227 views

·

3 months ago
22:27

Developmental Therapeutics Highlights From ASCO® 2024

2024 ASCO® Annual Meeting Insights Hub

G. Sonpavde

532 views

·

4 months ago
26:47

Updates in the Treatment and Management of Prostate Cancer

Integrity CE

S. Kadambi, B. Guercio, M. Galsky

140 views

·

3 months ago
AUTOPLAY